Skip to main content

Advertisement

SpringerLink
Log in

Genetic diversity of the apolipoprotein E gene and diabetic nephropathy: a meta-analysis

  • Published:
Molecular Biology Reports Aims and scope Submit manuscript

Abstract

In the past decade, a number of case–control studies have been carried out to investigate the relationship between the ApoE polymorphism and diabetic nephropathy. However, the results have been inconclusive. To investigate this inconsistency, we performed a meta-analysis of all available studies dealing with the relationship between the ApoE polymorphism and DN. The 23 studies in the meta- analysis included 6,012 diabetic patients with (n = 2,979) and without (n = 3,033) DN. The ApoE ε2 allele was significantly associated with DN (OR = 1.64, 95% CI: 1.26–2.13; P(Z) = 0.00027), whereas the ε4 allele was non-significantly associated with DN (OR = 0.93, 95% CI: 0.78–1.11; P(Z) = 0.418). However, significant heterogeneity was detected. In further subgroup analyses, genotyping methods, outcome of cases and duration of diabetes in controls were found to explain some of the heterogeneity. Genotypic analysis also found a strong association between the ε2 carriers and DN (OR = 1.61, 95% CI: 1.22–2.13; P(Z) = 0.001) and indicated that ε4 tended to have a marginally significant protective effect for DN (OR = 0.82, 95% CI: 0.65–1.03; P(Z) = 0.085). The results of our meta-analysis support a genetic association between the ApoE polymorphism and DN. ε2 increases the risk of DN in diabetes patients, while ε4 trends to be protective. These findings may have implications for therapeutic intervention in diabetic nephropathy.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2
Fig. 3

Similar content being viewed by others

Abbreviations

DN:

Diabetic Nephropathy

ApoE:

Apolipoprotein E

HWE:

Hardy-Weinberg equilibrium

OR:

Odds Ratio

CI:

Confidence Interval

References

  1. Gross JL et al (2005) Diabetic nephropathy: diagnosis, prevention, and treatment. Diabetes Care 28(1):164–176

    Article  PubMed  Google Scholar 

  2. Rippin JD, Patel A, Bain SC (2001) Genetics of diabetic nephropathy. Best Pract Res Clin Endocrinol Metab 15(3):345–358

    Article  PubMed  CAS  Google Scholar 

  3. Kimura H et al (1998) Apolipoprotein E4 reduces risk of diabetic nephropathy in patients with NIDDM. Am J Kidney Dis 31(4):666–673

    Article  PubMed  CAS  Google Scholar 

  4. Chowdhury TA et al (1999) Genetic determinants of diabetic nephropathy. Clin Sci (Lond) 96(3):221–230

    Article  CAS  Google Scholar 

  5. Joss N et al (2005) Influence of apolipoprotein E genotype on progression of diabetic nephropathy. Nephron Exp Nephrol 101(4):e127–e133

    Article  PubMed  CAS  Google Scholar 

  6. Quinn M et al (1996) Familial factors determine the development of diabetic nephropathy in patients with IDDM. Diabetologia 39(8):940–945

    Article  PubMed  CAS  Google Scholar 

  7. Ravid M et al (1998) Main risk factors for nephropathy in type 2 diabetes mellitus are plasma cholesterol levels, mean blood pressure, and hyperglycemia. Arch Intern Med 158(9):998–1004

    Article  PubMed  CAS  Google Scholar 

  8. Ha SK et al (1999) Association between apolipoprotein E polymorphism and macroalbuminuria in patients with non-insulin dependent diabetes mellitus. Nephrol Dial Transplant 14(9):2144–2149

    Article  PubMed  CAS  Google Scholar 

  9. Jandeleit-Dahm K et al (1999) Role of hyperlipidemia in progressive renal disease: focus on diabetic nephropathy. Kidney Int Suppl 71:S31–S36

    Article  PubMed  CAS  Google Scholar 

  10. Lam KS et al (1995) Cholesterol-lowering therapy may retard the progression of diabetic nephropathy. Diabetologia 38(5):604–609

    Article  PubMed  CAS  Google Scholar 

  11. Eto M et al (2002) Apolipoprotein E genetic polymorphism, remnant lipoproteins, and nephropathy in type 2 diabetic patients. Am J Kidney Dis 40(2):243–251

    Article  PubMed  CAS  Google Scholar 

  12. Park JS et al (2004) Apolipoprotein E genetic polymorphism and diabetic microangiopathy in type 2 diabetic patients. J Korean Diab Assoc 28:511–520

    Google Scholar 

  13. Krieger M, Herz J (1994) Structures and functions of multiligand lipoprotein receptors: macrophage scavenger receptors and LDL receptor-related protein (LRP). Annu Rev Biochem 63:601–637

    Article  PubMed  CAS  Google Scholar 

  14. Mahley RW (1988) Apolipoprotein E: cholesterol transport protein with expanding role in cell biology. Science 240(4852):622–630

    Article  PubMed  CAS  Google Scholar 

  15. Ha TS et al (2004) Regulation of glomerular endothelial cell proteoglycans by glucose. J Korean Med Sci 19(2):245–252

    Article  PubMed  CAS  Google Scholar 

  16. Moorhead JF et al (1982) Lipid nephrotoxicity in chronic progressive glomerular and tubulo-interstitial disease. Lancet 2(8311):1309–1311

    Article  PubMed  CAS  Google Scholar 

  17. Diamond JR (1991) Analogous pathobiologic mechanisms in glomerulosclerosis and atherosclerosis. Kidney Int Suppl 31:S29–S34

    PubMed  CAS  Google Scholar 

  18. DerSimonian R, Laird N (1986) Meta-analysis in clinical trials. Control Clin Trials 7(3):177–188

    Article  PubMed  CAS  Google Scholar 

  19. Zintzaras E, Hadjigeorgiou GM (2004) Association of paraoxonase 1 gene polymorphisms with risk of Parkinson’s disease: a meta-analysis. J Hum Genet 49(9):474–481

    Article  PubMed  Google Scholar 

  20. Woolf B (1955) On estimating the relation between blood group and disease. Ann Hum Genet 19(4):251–253

    Article  PubMed  CAS  Google Scholar 

  21. Egger M et al (1997) Bias in meta-analysis detected by a simple, graphical test. Bmj 315(7109):629–634

    PubMed  CAS  Google Scholar 

  22. Horita K, Eto M, Makino I (1994) Apolipoprotein E2, renal failure and lipid abnormalities in non-insulin-dependent diabetes mellitus. Atherosclerosis 107(2):203–211

    Article  PubMed  CAS  Google Scholar 

  23. Onuma T et al (1996) Apolipoprotein E genotypes and risk of diabetic nephropathy. J Am Soc Nephrol 7(7):1075–1078

    PubMed  CAS  Google Scholar 

  24. Chowdhury TA et al (1998) Association of apolipoprotein epsilon2 allele with diabetic nephropathy in Caucasian subjects with IDDM. Diabetes 47(2):278–280

    PubMed  CAS  Google Scholar 

  25. Tarnow L et al (2000) Plasminogen activator inhibitor-1 and apolipoprotein E gene polymorphisms and diabetic angiopathy. Nephrol Dial Transplant 15(5):625–630

    Article  PubMed  CAS  Google Scholar 

  26. Hadjadj S et al (2000) Lack of relationship in long-term type 1 diabetic patients between diabetic nephropathy and polymorphisms in apolipoprotein epsilon, lipoprotein lipase and cholesteryl ester transfer protein. Genetique de la Nephropathie Diabetique Study Group. Donnees Epidemiologiques sur le Syndrome d’Insulino-Resistance Study Group. Nephrol Dial Transplant 15(12):1971–1976

    Article  PubMed  CAS  Google Scholar 

  27. Araki S et al (2000) APOE polymorphisms and the development of diabetic nephropathy in type 1 diabetes: results of case-control and family-based studies. Diabetes 49(12):2190–2195

    Article  PubMed  CAS  Google Scholar 

  28. Shcherbak NS (2001) Apolipoprotein E gene polymorphism is not a strong risk factor for diabetic nephropathy and retinopathy in Type I diabetes: case-control study. BMC Med Genet 2:8

    Article  PubMed  CAS  Google Scholar 

  29. Akarsu E, Purum Ü (2001) A relation between the apolipoprotein E genotypes and microalbuminuria in type 2 diabetes mellitus. Turk J Med Sci 31:59–64

    CAS  Google Scholar 

  30. Orchard TJ et al (2002) Nephropathy in type 1 diabetes: a manifestation of insulin resistance and multiple genetic susceptibilities? Further evidence from the Pittsburgh Epidemiology of Diabetes Complication Study. Kidney Int 62(3):963–970

    Article  PubMed  CAS  Google Scholar 

  31. Hsieh MC et al (2002) Higher frequency of apolipoprotein E2 allele in type 2 diabetic patients with nephropathy in Taiwan. J Nephrol 15(4):368–373

    PubMed  CAS  Google Scholar 

  32. Araki S et al (2003) APOE polymorphism and the progression of diabetic nephropathy in Japanese subjects with type 2 diabetes: results of a prospective observational follow-up study. Diabetes Care 26(8):2416–2420

    Article  PubMed  CAS  Google Scholar 

  33. Liu L et al (2003) Co-inheritance of specific genotypes of HSPG and ApoE gene increases risk of type 2 diabetic nephropathy. Mol Cell Biochem 254(1–2):353–358

    Article  PubMed  CAS  Google Scholar 

  34. Ng MC et al (2006) Association of lipoprotein lipase S447X, apolipoprotein E exon 4, and apoC3–455T>C polymorphisms on the susceptibility to diabetic nephropathy. Clin Genet 70(1):20–28

    Article  PubMed  CAS  Google Scholar 

  35. Leiva E et al (2007) Relationship between Apolipoprotein E polymorphism and nephropathy in type-2 diabetic patients. Diabetes Res Clin Pract 78(2):196–201

    Article  PubMed  CAS  Google Scholar 

  36. Kwon MK et al (2007) Association between apolipoprotein E genetic polymorphism and the development of diabetic nephropathy in type 2 diabetic patients. Diabetes Res Clin Pract 77(Suppl 1):S228–S232

    Article  PubMed  CAS  Google Scholar 

  37. Ilhan N et al (2007) Apo E gene polymorphism on development of diabetic nephropathy. Cell Biochem Funct 25(5):527–532

    Article  PubMed  CAS  Google Scholar 

  38. Ma SW, Benzie IF, Yeung VT (2008) Type 2 diabetes mellitus and its renal complications in relation to apolipoprotein E gene polymorphism. Transl Res 152(3):134–142

    Article  PubMed  CAS  Google Scholar 

  39. Guan J et al (2009) Apolipoprotein E polymorphism and expression in type 2 diabetic patients with nephropathy: clinicopathological correlation. Nephrol Dial Transplant 24(6):1889–1895

    Article  PubMed  CAS  Google Scholar 

  40. Erdogan M et al (2009) The relationship of the apolipoprotein E gene polymorphismin Turkish Type 2 diabetic patients with and without nephropathy. J Endocrinol Invest 32(3):219–222

    PubMed  CAS  Google Scholar 

  41. Eto M et al (1995) Increased frequency of apolipoprotein epsilon 2 allele in non-insulin dependent diabetic (NIDDM) patients with nephropathy. Clin Genet 48(6):288–292

    Article  PubMed  CAS  Google Scholar 

  42. Xu MQ, St Clair D, He L (2006) Meta-analysis of association between ApoE epsilon4 allele and schizophrenia. Schizophr Res 84(2–3):228–235

    Article  PubMed  Google Scholar 

  43. Liberopoulos E, Siamopoulos K, Elisaf M (2004) Apolipoprotein E and renal disease. Am J Kidney Dis 43(2):223–233

    Article  PubMed  CAS  Google Scholar 

  44. Sato H et al (1991) Immunohistological localization of apolipoproteins in the glomeruli in renal disease: specifically apoB and apoE. Clin Nephrol 36(3):127–133

    PubMed  CAS  Google Scholar 

  45. Bruneval P et al (2002) Mesangial expansion associated with glomerular endothelial cell activation and macrophage recruitment is developing in hyperlipidaemic apoE null mice. Nephrol Dial Transplant 17(12):2099–2107

    Article  PubMed  CAS  Google Scholar 

  46. Chen G et al (2001) A protective role for kidney apolipoprotein E. Regulation of mesangial cell proliferation and matrix expansion. J Biol Chem 276(52):49142–49147

    Article  PubMed  CAS  Google Scholar 

Download references

Acknowledgments

This work was supported by grants (2006CB910600, 2007CB947300, 07DZ22917, and 09DJ1400601), by the Shanghai Leading Academic Discipline Project (B205), the Shanghai Municipality Science & Technology Commission (2008ZD001, 05JC14090,07DJ14005). the Chinese Academy of Sciences(KSCX2-YW-R-01) and the National Natural Science Foundation of China (30700203).

Author information

Authors and Affiliations

  1. Bio-X Center, Key Laboratory for the Genetics of Developmental and Neuropsychiatric Disorders (Ministry of Education), Shanghai Jiao Tong University, 1954 Huashan Road, Shanghai, 200030, China

    Yang Li, Kefu Tang, Zhao Zhang, Ming Zhang, Zhen Zeng, Zangdong He, Lin He & Chunling Wan

  2. Institutes for Nutritional Sciences, Shanghai Institute of Biological Sciences, Chinese Academy of Sciences, 320 Yueyang Road, Shanghai, 200031, China

    Yang Li, Kefu Tang, Zhao Zhang, Ming Zhang, Zhen Zeng, Zangdong He, Lin He & Chunling Wan

  3. Institutes of Biomedical Sciences, Fudan University, 130 Dongan Road, Shanghai, 200032, China

    Lin He

Authors
  1. Yang Li
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Kefu Tang
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Zhao Zhang
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Ming Zhang
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Zhen Zeng
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Zangdong He
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Lin He
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. Chunling Wan
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding authors

Correspondence to Lin He or Chunling Wan.

Electronic supplementary material

Below is the link to the electronic supplementary material.

Supplementary material 1 (DOC 155 kb)

Supplementary material 2 (DOC 209 kb)

Rights and permissions

Reprints and permissions

About this article

Cite this article

Li, Y., Tang, K., Zhang, Z. et al. Genetic diversity of the apolipoprotein E gene and diabetic nephropathy: a meta-analysis. Mol Biol Rep 38, 3243–3252 (2011). https://doi.org/10.1007/s11033-010-9999-z

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11033-010-9999-z

Keywords

Search

Navigation